Part 1: Hepatobiliary What ??

Part 3: Regulations/ Access & Equity

Part 3: Cross talk with cardiopulmonary and renal systems

Leading experts in clinical program implementation will focus on how to design and implement clinical care models and programs along the continuum of liver disease care, from viral hepatitis elimination to multidisciplinary care for liver cancer; inpatien

Presenter: Sumeet Asrani, MD, MSc
Liver Transplantation remains important in the management of patients with alcohol associated liver disease that have liver decompensation or develop complications. This session will address some recent advances as well

Presenter: Laura James, MD
Available diagnostic tests for acetaminophen acute liver injury are time-limited and non-specific. Acetaminophen protein adducts, formed by oxidative metabolism, can be detected in serum, are highly sensitive and specific, and

The role of systemic therapy for HCC continues to evolve beyond traditional advanced stage disease to patients with intermediate and early stage tumors. This session will highlight the changing landscape of HCC for advanced stage disease, examine the exis

This session is focused on mechanistic, translational and clinical aspects of drug-induced liver injury (DILI). Speakers will share an update on the traditional chemotherapy DILI and discuss liver-related side effects of novel cancer chemotherapeutics, su

Part 1: Weight Management in cirrhosis and PRE-Transplant candidates: Medical vs Endobariatric vs surgical management

Part 2: Health Disparities in Underrepresented & Unique Populations